至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Deciphering the Mechanism: Overcoming Incompatibility for Continuous Cap‑1 mRNA Synthesis via Multienzyme Cascades

ACS Sustainable Chemistry & Engineering. 2026-03; 
Shiyi Che, , Zhengjun Li, Zhiguo Su, Aibing Yu, Minsu Liu, and Songping Zhang
Products/Services Used Details Operation
Gene Synthesis The ribozyme for mRNA cleavage was synthesized by GenScript (Nanjing, China). Get A Quote

摘要

Efficient synthesis of cap-1 mRNA is limited by low recovery and degradation risks in conventional multistep enzymatic reactions which require multiple intermediate separations. Here, we execute a mechanism-driven one-pot multienzyme cascade catalyzed by T7 RNA polymerase (T7-RNAP), vaccinia capping enzyme (VCE), and 2′-O-methyltransferase (2′-O-MTase) for continuous synthesis of cap-1 mRNA, where competitive interactions between Mg2+ and VCE activity are deciphered. It is generally regarded that excess Mg2+ promotes transcription but suppresses the capping; however, in our integrated cascade system, VCE exhibits largely enhanced tolerance to Mg2+, which was uncovered due to the competitive binding effects ... More

关键词